Product image of Evra (Ethinylestradiol, Norelgestromin) supplied by GNH India

Evra

Active Ingredient:
Ethinylestradiol, Norelgestromin
Origin:
EU

Evra (Ethinylestradiol, Norelgestromin)

Evra is a transdermal contraceptive patch containing Ethinylestradiol and Norelgestromin. It is designed to prevent pregnancy by delivering hormones through the skin. This patch is a convenient option for those seeking hormonal birth control.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Evra is primarily used for birth control. The patch releases hormones that prevent ovulation and thicken cervical mucus, making it harder for sperm to reach the egg. It is applied once a week for three weeks, followed by a one-week patch-free period. Evra is often considered for those who prefer a non-daily contraceptive method.

Side Effects

  • Common effects of Evra may include skin irritation at the application site, breast tenderness, headaches, and nausea. Some users may also experience changes in menstrual bleeding patterns. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

  • Evra should be used with caution in individuals with a history of blood clots, high blood pressure, or certain types of cancer. It is important to follow the prescribed application schedule and monitor for any signs of allergic reactions or severe side effects. Regular check-ups with a healthcare provider are recommended.

Avoid Interactions

  • Evra may interact with certain medications, including those that affect liver enzymes, such as some antibiotics and antifungal drugs. It is advisable to consult a healthcare provider before starting or stopping any new medications while using Evra. Alcohol and smoking may also affect the effectiveness and safety of the patch.

Frequently Asked Questions

Evra is used for birth control. It is a transdermal patch that releases hormones to prevent pregnancy.

The Evra patch should be changed once a week for three weeks, followed by a one-week patch-free period.

Yes, skin irritation at the application site is a common effect of Evra.

If you experience severe side effects, remove the patch and consult a healthcare provider immediately.

Evra should be used with caution in individuals with a history of blood clots. Consult a healthcare provider before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Norelgestromin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT